SCHEMBL21233358

SCHEMBL21233358

CC1O[C@H](C)C(OC2OC(COC3OC(C(=O)O)C(O)C(O)C3O)C(O)C(O)C2O)C(O)C1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CD209 Q9NNX6 2/20 0.41
▸ BDNF P23560 2/20 0.40
▸ PTN P21246 1/20 0.40
▸ MDK P21741 1/20 0.40
▸ PRKCA P17252 2/20 0.39
▸ AMY2A P04746 2/20 0.39
▸ FGF2 P09038 1/20 0.39
▸ AMY1A P0DUB6 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ ENGASE Q8NFI3 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP12 P39900 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ KDM1A O60341 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21233263 1.00 CD209 (0.41) CD209BDNFPTNMDKPRKCA
SCHEMBL22778359 0.90 F10 (0.41) CD209BDNFPTNMDKPRKCA
SCHEMBL19773431 0.90 F10 (0.41) CD209BDNFPTNMDKPRKCA
SCHEMBL22778350 0.90 F10 (0.41) CD209BDNFPTNMDKPRKCA
SCHEMBL21233365 0.90 F10 (0.41) CD209BDNFPTNMDKPRKCA
SCHEMBL24080164 0.90 F10 (0.41) CD209BDNFPTNMDKPRKCA
SCHEMBL21233245 0.90 F10 (0.41) CD209BDNFPTNMDKPRKCA
SCHEMBL19773367 0.90 F10 (0.41) CD209BDNFPTNMDKPRKCA
SCHEMBL21233406 0.87 F10 (0.43) CD209BDNFPTNMDKPRKCA
SCHEMBL19027009 0.85 F10 (0.37) CD209BDNFPTNMDKPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11191822-B2 Pneumococcal polysaccharide-protein conjugate composition MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2021-12-07 — — US disclosed
US-10864261-B2 Synthetic vaccines against Streptococcus pneumoniae serotype 2 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2020-12-15 — — US disclosed
US-20190240309-A1 PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2019-08-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10864261-B2 Synthetic vaccines against Streptococcus pneumoniae serotype 2 FUT5, SIGLEC7, ST6GAL1 CD209 341/4885BDNF 3022/4885PTN 2160/4885
US-20190240309-A1 PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION STT3A, STT3B, DDOST CD209 775/4885BDNF 3592/4885PTN 1105/4885
US-11191822-B2 Pneumococcal polysaccharide-protein conjugate composition STT3A, STT3B, DDOST CD209 775/4885BDNF 3592/4885PTN 1105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback